Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
Public ClinicalTrials.gov record NCT01722487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 versus Chlorambucil in Patients 65 Years or Older with Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.
Study identification
- NCT ID
- NCT01722487
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 269 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2013 (Type not available)
- Primary completion
- May 2015 (Actual)
- Completion
- May 2015 (Actual)
- Last update posted
- Nov 30, 2017
2013 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator #047 | Duarte | California | 91010 | — |
| Site Reference ID/Investigator #408 | La Jolla | California | 92093 | — |
| Site Reference ID/Investigator #720 | Santa Rosa | California | 95403 | — |
| Site Reference ID/Investigator #038 | Stanford | California | 94305 | — |
| Site Reference ID/Investigator #125 | Atlanta | Georgia | 30318 | — |
| Site Reference ID/Investigator #126 | Chicago | Illinois | 60637 | — |
| Site Reference ID/Investigator #071 | Louisville | Kentucky | 40207 | — |
| Site Reference ID/Investigator #307 | Worcester | Massachusetts | 01655 | — |
| Site Reference ID/Investigator #387 | Ann Arbor | Michigan | 48109 | — |
| Site Reference ID/Investigator #221 | St Louis | Missouri | 63110 | — |
| Site Reference ID/Investigator #712 | Las Vegas | Nevada | 89169 | — |
| Site Reference ID/Investigator #350 | New Hyde Park | New York | 11042 | — |
| Site Reference ID/Investigator #127 | Rochester | New York | 14642 | — |
| Site Reference ID/Investigator #656 | Goldsboro | North Carolina | 27534 | — |
| Site Reference ID/Investigator #734 | Columbus | Ohio | 43219 | — |
| Site Reference ID/Investigator #677 | Portland | Oregon | 97227 | — |
| Site Reference ID/Investigator #050 | Pittsburgh | Pennsylvania | 15232 | — |
| Site Reference ID/Investigator #032 | Houston | Texas | 77030 | — |
| Site Reference ID/Investigator #381 | Laredo | Texas | 78041 | — |
| Site Reference ID/Investigator #653 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator #404 | Seattle | Washington | 98109 | — |
| Site Reference ID/Investigator #731 | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01722487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01722487 live on ClinicalTrials.gov.